Sandeeran Chemicals Company Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
as on 16-11-2024
- Paid Up Capital ₹ 1.03 M
as on 16-11-2024
- Company Age 41 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 M
as on 16-11-2024
- Satisfied Charges ₹ 0.50 M
as on 16-11-2024
- Revenue 751.31%
(FY 2023)
- Profit -130.04%
(FY 2023)
- Ebitda -128.47%
(FY 2023)
- Net Worth -26.20%
(FY 2023)
- Total Assets 15.02%
(FY 2023)
About Sandeeran Chemicals Company
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 1.03 M.
The company currently has active open charges totaling ₹1.50 M. The company has closed loans amounting to ₹0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Praveen Khetwani, Kumar Chawla, and Navin Karira serve as directors at the Company.
- CIN/LLPIN
U24110MH1983PTC030819
- Company No.
030819
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Sep 1983
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sandeeran Chemicals Company?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praveen Khetwani  | Director | 03-Jul-2023 | Current |
| Kumar Chawla | Director | 22-Jul-2023 | Current |
| Navin Karira | Director | 03-Jul-2023 | Current |
Financial Performance of Sandeeran Chemicals Company.
Sandeeran Chemicals Company Pvt. Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 751.31% increase. The company also saw a substantial fall in profitability, with a 130.04% decrease in profit. The company's net worth observed a substantial decline by a decrease of 26.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sandeeran Chemicals Company?
In 2023, Sandeeran Chemicals Company had a promoter holding of 55.87% and a public holding of 44.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Oriental Bank Of India Creation Date: 10 Jan 1985 | ₹1.50 M | Open |
Central Bank Of India Creation Date: 25 Jan 1985 | ₹0.50 M | Satisfied |
How Many Employees Work at Sandeeran Chemicals Company?
Unlock and access historical data on people associated with Sandeeran Chemicals Company, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sandeeran Chemicals Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sandeeran Chemicals Company's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
